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self-rated health and the risk of 
incident type 2 diabetes mellitus: A 
cohort study
Jin-Won Noh1,2, Yoosoo Chang  3,4,5, Minsun park6, Young Dae Kwon7 & Seungho Ryu3,4,5
We aimed to evaluate the association between self-rated health (SRH) and the risk of incident type 2 
diabetes mellitus (T2D). This cohort study consisted of 250,805 Korean men and women without T2D at 
baseline. SRH was assessed at baseline with a self-administered structured questionnaire. Incident T2D 
was defined as fasting serum glucose ≥126 mg/dL, HbA1C ≥6.5%, or use of medication for T2D during 
follow-up. After adjustment for possible confounders including age, center, year of screening exam, 
smoking status, alcohol intake, physical activity, education level, total calorie intake, body mass index, 
sleep duration, depressive symptoms, family history of diabetes, history of hypertension, and history 
of cardiovascular disease, the multivariable-adjusted hazard ratios (95% confidence intervals) for 
incident T2D comparing good, fair, and poor or very poor SRH to very good SRH were 1.20 (0.98–1.48), 
1.63 (1.33–1.98), and 1.83 (1.47–2.27), respectively. These associations were consistently observed in 
clinically relevant subgroups. Fair or poorer SRH was independently and positively associated with the 
development of T2D in a large-scale cohort study of apparently healthy Korean adults, indicating that 
SRH is a predictor of metabolic health. Physicians involved in diabetes screening and management 
should routinely consider SRH when evaluating T2D risk as well as overall health.
The prevalence and incidence of type 2 diabetes mellitus (T2D) is increasing worldwide, and is accompanied 
by considerable mortality1. In 2017, the International Diabetes Federation reported that 425 million people had 
diabetes worldwide, and this prevalence is expected to rise to 629 million by 20452. In Korea and other Asian 
countries, diabetes has become a major cause of morbidity and mortality as well3,4. In total, 8.8% of Koreans had 
diabetes in 2017, and this prevalence is expected to rise to 12.1% by 20452. T2D is associated with increased risk 
of cardiovascular, cancer, respiratory, and all-cause mortality and is related to poor quality of life5,6. Although the 
pathogenesis of T2D has not been fully elucidated, interrelated genetic, behavioral, and environmental risk factors 
are thought to contribute to the development of T2D7. Given the rising burden of T2D and its complications, it is 
important to develop preventive strategies for identifying high-risk individuals before they develop T2D and to 
identify potentially modifiable risk factors.
Self-rated health (SRH) is an individual’s subjective perception of their own health status and is one of the 
most widely used measures of general health in population health research8. SRH has attracted attention as an 
independent predictor of cardiovascular disease, stroke, lung disease, arthritis, functional impairment, depres-
sion, and overall mortality9. The strength of SRH is its ability to sum up the net effect of multiple risk factors, 
possibly including unmeasured risk factors10. SRH is associated with lifestyle factors such as physical activity, 
overweight or obesity, smoking, unhealthy meal planning choices, alcohol consumption, and genetic factors, 
all of which are also associated with T2D11–13. Prior studies have also reported a positive association between 
poorer SRH and elevated inflammatory markers, a risk factor for T2D14–16. Several studies found an association 
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between poorer SRH and T2D using a cross-sectional design17,18, which is limited by the temporal ambiguity of 
exposure and outcome. Two cohort studies demonstrated that poorer SRH predicted increased risk of incident 
diabetes19,20. However, these studies did not consider important confounders such as sleep and depression21,22 
while examining the association between SRH and a self-reported diagnosis of T2D, and they were performed 
in Western countries17,19,20,23. Studies on SRH have rarely included Asian groups, although cultural factors may 
affect SRH. Therefore, the aim of this cohort study was to evaluate self-rated health and the risk of incident T2D 
in a large sample of apparently healthy Korean men and women who participated in a health screening program.
Materials and Methods
Study population. The Kangbuk Samsung Health Study is a cohort study of Korean men and women who 
underwent a comprehensive annual or biennial health examination at the Kangbuk Samsung Hospital Health 
Screening Centers in Seoul and Suwon, South Korea24. Over 80% of participants were employees of various 
companies and local governmental organizations and their spouses. In South Korea, annual or biennial health 
screening exams of employees are required by the Industrial Safety and Health Law. The remaining participants 
voluntarily purchased a self-paid health checkup exam.
The study population consisted of examinees who underwent comprehensive examination between January 1, 
2011 and December 31, 2016 and who had at least one follow-up visit through December 31, 2017 (n = 276,244). 
We excluded participants who had any of the following conditions at baseline: missing data for SRH, glucose, or 
HbA1c (n = 10,336); a history of malignancy (n = 6,245); and T2D at baseline (n = 10,170). Because some indi-
viduals met more than one exclusion criterion, the total number of subjects included in the study was 250,805 
(Fig. 1).
This study was designed to use de-identified data routinely collected as part of health screening examinations 
where questionnaire, blood tests and procedures (ultrasound, endoscopy, mammograms, etc.) are components of 
health screening exams. We use a computer system that automatically anonymizes and assigns study numbers for 
research purposes. The study was approved by the Institutional Review Board of Kangbuk Samsung Hospital (IRB 
No. KBSMC 2017-08-044), which waived the requirement for informed consent as we used only de-identified 
data obtained as part of routine health screening exams.
Measurements. Data on demographic characteristics, health behaviors, education level, and medical history 
were collected by standardized, self-administered questionnaires, as previously described25. Health behaviors and 
education levels were categorized as follows: smoking status (never, former, or current smoker), alcohol consump-
tion (≤20 g/day and >20 g/day), and education level (less than college graduate or college graduate or more). 
Family history of diabetes were defined as a self-reported diagnosis of diabetes in one or more first-degree rela-
tives. Physical activity levels and sitting time were assessed using the validated Korean version of the International 
Physical Activity Questionnaire Short Form25,26. Physical activity levels were classified into three categories: inac-
tive, minimally active, and health-enhancing physical activity (HEPA)25. Usual dietary consumption was assessed 
using a 106-item self-administered food frequency questionnaire designed and validated for use in Korea27. Sleep 
duration was assessed with the Pittsburgh Sleep Quality Index (PSQI)28. The PSQI has been validated for use in 
Korea29. One item in the PSQI asks about the duration of actual sleep at night in a typical 24 hour period over the 
past month. Sleep duration was categorized as ≤5, 6, 7, 8, or ≥9 hr. Depression was assessed using the Korean ver-
sion30 of the Center for Epidemiologic Studies Depression (CES-D) Scale31. Depressive symptoms were defined 
as a CES-D score ≥16 and <25, and clinical depression was defined as a CES-D score ≥25. SRH was assessed 
at baseline using a self-administered questionnaire in Korean in order to measure general health32, defined by 
responses to a single question such as “In general, how would you rate your health?” with the possible choices 
being “very good” (1), “good” (2), “fair” (3), “poor” (4) or “very poor” (5)33. There have been a number of studies 
investigating the content validity of SRH in populations of various ethnicities and races32,34.
Height and weight were measured by trained nurses. Height was measured to the nearest 0.1 cm using a 
stadiometer with the examinee standing without shoes. Weight was measured in a light gown while barefoot 
to the nearest 0.1 kg using a bioimpedance analyzer (InBody 3.0 and Inbody 720, Biospace Co., Seoul Korea). 
Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared (kg/m2) and obesity was 
defined as BMI ≥25 kg/m2, the proposed cutoff for diagnosis of obesity in Asian populations35. Blood pres-
sure was measured using an automated oscillometric device (53000, Welch Allyn, New York, United States of 
America) by trained nurses while examinees were a sitting position with the arm supported at the heart level. 
Hypertension was defined as a systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or cur-
rent use of antihypertensive medication. T2D was defined as a fasting serum glucose ≥126 mg/dL, hemoglobin 
A1c (HbA1c) ≥ 6.5%, or current use of insulin or anti-diabetic medications.
Serum biochemical parameters were measured, including glucose, HbA1c, alanine aminotransferase (ALT), 
insulin, total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein 
cholesterol (HDL-C) and are described in detail elsewhere25. Insulin resistance was assessed with the homeo-
static model assessment – insulin resistance (HOMA-IR) equation: fasting blood insulin (uU/ml) × fasting blood 
glucose (mmol/l)/22.5. The Laboratory Medicine Department at Kangbuk Samsung Hospital in Seoul, Korea is 
accredited by the Korean Society of Laboratory Medicine and the Korean Association of Quality Assurance for 
Clinical Laboratories. The laboratory participates in College of American Pathologists Survey Proficiency Testing.
Statistical analyses. Characteristics of the study participants were explored according to SRH and were 
compared according to SRH category using a linear regression test for continuous variables or a χ2 test for cat-
egorical variables. To test for linear trends, category numbers were used as continuous variables in regression 
models. SRH was categorized as follows; very good, good, fair, poor, or very poor. Since few subjects identified 
themselves as having very poor health (only 0.2%), we combined the poor and very poor categories.
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Development of T2D was the primary endpoint of this study. Person-years were calculated as the sum of the 
follow-up duration from baseline until the development of T2D or until the final examination conducted prior 
to December 31 2017, whichever came first. The incidence rate was calculated as the number of incident cases 
divided by person-years of follow-up. Since we knew that T2D had occurred at some point between the two visits 
but did not know the precise timing of development, we used a parametric proportional hazard model to account 
for this type of interval censoring (stpm command in Stata)36. In these models, the baseline hazard function was 
parameterized with restricted cubic splines in log time with four degrees of freedom.
We estimated the adjusted hazard ratio (aHR) with a 95% confidence interval (CI) for incident T2D. Statistical 
models were initially adjusted for age and sex and then for year of screening exam, center, smoking status, alcohol 
intake, physical activity, family history of diabetes, education level, sleep duration, CES-D, total calorie intake, 
BMI, history of hypertension, and history of cardiovascular disease. Sensitivity analysis was conducted after 
implementing a 2-year wash-out period, during which any incident T2D cases identified were excluded. This 
approach was taken to assess if the original results may have been influenced by reverse causality in which T2D 
was present, but undiagnosed. We assessed the proportional hazards assumption by examining graphs of esti-
mated log (-log) survival.
In addition, we performed stratified analyses in pre-specified subgroups defined by age (<50 vs. ≥50 years), 
sex (men vs. women), smoking (current smoker vs. noncurrent smoker), alcohol intake (<20 vs. ≥20 g/day), 
physical activity (no HEPA vs. HEPA), BMI (<25 vs. ≥25 kg/m2), HOMA-IR (<2.5 vs. ≥2.5), and high sensitivity 
C-reactive protein (hsCRP) (<1.0 vs. ≥1.0 mg/l). Interactions by subgroup characteristics were tested using like-
lihood ratio tests comparing models with and without multiplicative interaction terms. Statistical analyses were 
performed using STATA version 15.0 (StataCorp LP, College Station, TX, USA). All p-values were two-tailed, and 
p-values < 0.05 were considered statistically significant.
Results
The baseline characteristics of the study population are described in Table 1. The mean (SD) age and BMI of study 
participants were 38.3 (7.7) years and 23.2 (3.3) kg/m2, respectively. Subjects with better SRH were more likely to 
be male, older, and highly educated and less likely to be obese, a current smoker, drink alcohol, or have a history 
of cardiovascular disease or hypertension. They also had lower levels of BMI (kg/m2), systolic BP (mmHg), total 
cholesterol (mg/dl), LDL-C (mg/dl), triglycerides (mg/dl), ALT (U/l), HOMA-IR, and CES-D and higher levels 
of HEPA (%), HDL-C (mg/dl), sleep duration, and total energy intake (kcal/day).
Table 2 shows the development of diabetes according to SRH category. During 943,011.5 person-years of 
follow-up, 6,237 participants developed T2D (incidence rate 6.6 per 1,000 person-years) over a median follow-up 
period of 3.9 years (interquartile range, 2.1–5.3 years). Study participants were followed annually or biennially 
and the median frequency (interquartile range) of follow-up visits was 3 (2–5). The poorer SRH category was sig-
nificantly associated with an increased incidence of T2D (P for trend <0.001). In the age and sex-adjusted model, 
HRs (95% CI) for T2D comparing the “good”, “fair” or “poor or very poor” vs. the “very good” self-rated health 
category were 1.15 (0.96–1.36), 1.76 (1.48–2.08), and 2.70 (2.25–3.24), respectively. This association persisted 
after further adjusting for center, year of screening exam, smoking status, alcohol intake, physical activity, educa-
tion level, family history of diabetes, total calorie intake, BMI, history of hypertension, history of cardiovascular 
disease, sleep duration, and CES-D. Corresponding multivariable-adjusted HRs (95% CI) for T2D comparing 
the “good,” “fair,” or “poor or very poor” vs. the “very good” self-rated health category were 1.20 (0.98–1.48), 1.63 
(1.33–1.98), and 1.83 (1.47–2.27), respectively. In sensitivity analysis after excluding subjects who developed 
T2D within the first 2 years of follow-up, the associations of SRH with incident T2D were essentially unchanged 
(Appendix Table 2).
In pre-specified subgroup analyses (Table 3), associations between SRH and incident diabetes were stronger 
patients with an alcohol intake of <20 g/day compared to those with an alcohol intake of ≥20 g/day (P for 
Figure 1. Selection of the study population. Of the people who were examined between January 1, 2011 and 
December 31, 2016, 276,244 had at least one follow-up visit by December 31, 2017, and 250,805 were eventually 
included in the study. T2D, type 2 diabetes mellitus.
4Scientific RepoRts |          (2019) 9:3697  | https://doi.org/10.1038/s41598-019-40090-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
interaction = 0.009). Otherwise, their associations were similar with no significant interactions between sub-
groups stratified by age (<50 vs. ≥50 years), sex (women vs. men), smoking status (noncurrent smoker vs. cur-
rent smoker), alcohol intake (<20 vs. ≥20 g/day), physical activity (no HEPA vs. HEPA), BMI (<25 vs. ≥25 kg/
m2), HOMA-IR (<2.5 vs. ≥2.5) or hsCRP (<1.0 vs. ≥1.0 mg/L).
Discussion
In a large-scale cohort study of 250,805 young and middle-aged Korean men and women, poorer SRH was sig-
nificantly associated with a higher risk of T2D in a dose-dependent manner. In our study, poorer SRH showed a 
graded positive association with depressive symptoms, which is in line with previous studies37,38. However, the 
association of fair or poorer SRH with incident T2D persisted even after adjustment for potential confounders, 
Characteristics Overall
Self-rated health category P for 
trendVery good Good Fair Poor or very poor
Number 250,805 7,641 75,911 148,037 19,216 <0.001
Age (years)a 38.3 (7.7) 39.2 (8.8) 38.5 (8.0) 38.3 (7.5) 37.6 (7.7) <0.001
Male (%) 55.0 63.8 60.3 52.6 49.0 <0.001
Current smoker (%) 27.8 24.0 27.0 28.3 29.8 <0.001
Alcohol intake (%)b 23.0 22.7 23.5 22.6 24.6 0.963
HEPA (%) 15.7 31.8 20.7 13.0 10.4 <0.001
High education level (%)c 84.1 85.1 86.3 83.4 80.3 <0.001
History of CVD (%) 0.8 0.6 0.7 0.8 1.6 <0.001
Hypertension (%) 9.3 6.8 8.00 9.6 13.1 <0.001
Family history of diabetes (%)
Sleep duration (hours) 6.0 (6.0–7.0) 7.0 (6.0–7.0) 7.0 (6.0–7.0) 6.0 (6.0–7.0) 6.0 (6.0–7.0) <0.001
CESD –D ≥ 16 (%) 11.2 3.6 5.4 12.0 30.1 <0.001
Obesity (%) 26.7 25.0 25.1 26.8 32.6 <0.001
BMI (kg/m2) 23.2 (3.3) 23.2 (2.8) 23.1 (3.0) 23.1 (3.3) 23.5 (4.1) <0.001
Systolic BP (mmHg)a 109.0 (13.0) 109.3 (12.4) 109.3 (12.7) 108.8 (13.1) 108.5 (13.4) <0.001
Diastolic BP (mmHg)a 69.8 (9.9) 69.5 (9.4) 69.8 (9.7) 69.9 (10.0) 69.8 (10.2) 0.058
Glucose (mg/dl)a 93.5 (8.5) 93.3 (8.6) 93.4 (8.5) 93.5 (8.5) 93.4 (8.6) 0.254
Total cholesterol (mg/dl)a 193.6 (33.7) 191.8 (32.4) 192.8 (32.8) 193.9 (34.0) 194.3 (35.6) <0.001
LDL-C (mg/dl)a 119.6 (31.6) 117.5 (30.3) 118.9 (30.8) 120.0 (31.9) 120.5 (33.3) <0.001
HDL-C (mg/dl)a 58.8 (15.1) 60.5 (15.2) 59.4 (15.0) 58.6 (15.1) 57.6 (15.0) <0.001
Triglycerides (mg/dl)d 89 (63–132) 83 (60–121) 87 (63–127) 90 (64–134) 93 (66–141) <0.001
ALT (U/l)d 18 (13–27) 17 (13–24) 18 (13–26) 18 (12–27) 18 (12–30) <0.001
HOMA-IRd 1.16 (0.77–1.71) 1.04 (0.69–1.52) 1.10 (0.73–1.60) 1.18 (0.78–1.75) 1.28 (0.83–1.96) <0.001
hsCRP (mg/l)d 0.4 (0.2–0.9) 0.4 (0.2–0.7) 0.4 (0.2–0.8) 0.4 (0.2–0.9) 0.5 (0.3–1.1) <0.001









Table 1. Baseline characteristics of study participants by self-rated health. Data are presented as aMeans 
(standard deviation), dMedians (interquartile range), or percentages. Abbreviations: ALT, alanine 
aminotransferase; BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; HDL-C, high-
density lipoprotein-cholesterol; hsCRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model 
assessment of insulin resistance. b≥20 g of ethanol per day c≥college graduate. eAmong 175,345 participants 








Incidence density (per 
1,000 person-years)




Very good 28,003.4 139 5.0 1.00 (reference) 1.00 (reference)
Good 290,116.1 1,501 5.2 1.15 (0.96–1.36) 1.20 (0.98–1.48)
Fair 555,687.4 3,929 7.1 1.76 (1.48–2.08) 1.63 (1.33–1.98)
Poor or very 
poor 69,204.6 668 9.7 2.70 (2.25–3.24) 1.83 (1.47–2.27)
P for trend <0.001 <0.001
Table 2. Development of diabetes by self-rated health category. aEstimated from parametric proportional 
hazard models. The multivariable model was adjusted for age, sex, center, year of screening exam, smoking 
status, alcohol intake, physical activity, education level, total calorie intake, BMI, sleep duration, CESD, family 
history of diabetes, history of hypertension, and history of cardiovascular disease. Abbreviations: BMI, body 
mass index; CESD, Center for Epidemiologic Studies Depression; CI, confidence intervals; HR, hazard ratios.
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including demographic characteristics, anthropometrics, comorbidities, lifestyle factors and depressive 
symptoms, indicating that the association of SRH with the development of T2D cannot be fully explained by 
health-related variables, depression, or other comorbidities. Our findings suggest that SRH may be an independ-
ent predictor of metabolic disease such as diabetes, even in a relatively healthy low-risk population.
Although SRH has been investigated in various health conditions such as cardiovascular disease, stroke, 
lung disease, arthritis, functional impairment, depression, and overall mortality9, only two previous cohort 
studies examined the association between SRH and T2D incidence in Europe and the United States. In a 
population-based prospective case-cohort study of 3,399 incident type 2 diabetic case participants and a sub-
cohort of 4,619 participants across several European countries with a mean follow-up of 9.1 years, Wennberg 
et al. reported that low SRH (moderate or poor) was associated with a higher risk of T2D compared with high 
(excellent or good), with a multivariable-adjusted HR (95% CI) of 1.29 (1.09–1.53)19. In our study, an almost 
two-fold increase in risk for incident T2D was observed with poor or very poor SRH compared to the very good 
SRH category, with a fully-adjusted HR (95% CI) of 1.83 (1.47–2.27). Another cohort study by Latham and Peek 
evaluated the association between SRH and self-diagnosis of major chronic diseases including diabetes among 
4,770 adults aged 51 to 61 years20. In this study, each unit increase in SRH (higher scores indicate better health) 
was inversely associated with a 0.82 times lower risk of subsequent T2D20. The different findings across studies 
could be attributable to differences in sample size, study population (age, ethnicity, and sex composition), meas-
ures of T2D, use of a reference group and controlling for potential confounding factors. In particular, no previous 
studies determined incident diabetes based on objective measures such as laboratory testing of fasting blood 
glucose and HbA1c. This is important, as some proportion of diabetic patients can remain undiagnosed without 
screening, resulting in misclassification errors when detecting T2D as an outcome39. Furthermore, SRH can be 
related to sleep and mental health issues such as depression, but none of the former studies considered those to 
be important confounders21,40. In our study, poorer SRH showed graded and positive association with depressive 
symptoms37,38. Likewise, in previous studies, depressive symptoms were significantly associated to with poorer 
SRH37,38. In our study, fair or poorer SRH was independently associated with higher risk of incident T2D even 
after adjustment for depressive symptoms and other confounders.
The strengths of the present study are the large sample size, the prospective cohort study design, the use 






interactionVery good Good Fair
Poor or very 
poor
Age 0.327
<50 years (N = 231,069) Reference 1.10 (0.87–1.38) 1.51 (1.20–1.89) 1.61 (1.27–2.06) <0.001
≥50 years (N = 19,736) Reference 1.46 (0.96–2.25) 1.73 (1.14–2.64) 1.93 (1.19–3.12) <0.001
Sex 0.880
Female (N = 112,931) Reference 1.01 (0.63–1.62) 1.42 (0.90–2.24) 1.59 (0.99–2.57) <0.001
Male (N = 137,874) Reference 1.24 (0.99–1.55) 1.67 (1.34–2.09) 1.88 (1.47–2.39) <0.001
Current smoking 0.826
No (N = 163,449) Reference 1.20 (0.92–1.58) 1.66 (1.27–2.17) 1.91 (1.43–2.55) <0.001
Yes (N = 63,062) Reference 1.26 (0.87–1.81) 1.65 (1.16–2.36) 1.81 (1.24–2.63) <0.001
Alcohol intake 0.009
<20 g/day (N = 181,455) Reference 1.35 (1.01–1.79) 1.88 (1.42–2.48) 2.37 (1.76–3.18) <0.001
≥20 g/day (N = 54,208) Reference 1.05 (0.77–1.44) 1.33 (0.98–1.80) 1.34 (0.96–1.87) <0.001
HEPA 0.375
No (N = 209,494) Reference 1.18 (0.91–1.52) 1.57 (1.23–2.02) 1.82 (1.40–2.37) <0.001
Yes (N = 39,068) Reference 1.22 (0.87–1.72) 1.75 (1.26–2.45) 1.59 (1.05–2.41) <0.001
Body mass index 0.331
<25 kg/m2 (N = 183,745) Reference 1.00 (0.75–1.32) 1.34 (1.02–1.76) 1.52 (1.11–2.07) <0.001
≥25 kg/m2 (N = 66,871) Reference 1.43 (1.06–1.92) 1.94 (1.45–2.60) 2.20 (1.62–2.99) <0.001
HOMA-IR 0.822
<2.5 (N = 226,602) Reference 1.10 (0.88–1.37) 1.45 (1.17–1.81) 1.58 (1.23–2.02) <0.001
≥2.5 (N = 22,710) Reference 1.38 (0.84–2.28) 1.80 (1.10–2.95) 2.05 (1.23–3.39) <0.001
hsCRP 0.683
<1.0 mg/l (N = 160,098) Reference 1.34 (0.99–1.80) 1.74 (1.29–2.34) 2.05 (1.49–2.83) <0.001
≥1.0 mg/l (N = 45,947) Reference 1.32 (0.88–2.00) 1.84 (1.23–2.76) 1.96 (1.29–2.99) <0.001
Table 3. Hazard ratiosa (95% CI) of incident diabetes according to self-rated health category in clinically 
relevant subgroups. aEstimated from parametric proportional hazard models adjusted for age, sex, center, year 
of screening exam, smoking status, alcohol intake, physical activity, education level, total calorie intake, BMI, 
sleep duration, CES-D, family history of diabetes, history of hypertension and history of cardiovascular disease. 
Abbreviations: HEPA, health-enhancing physical activity; hsCRP, high sensitivity C-reactive protein; and 
HOMA-IR, homeostasis model assessment.
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lifestyle factors including smoking, alcohol consumption, physical activity, diet, and sleep. More importantly, in 
our study, fasting blood glucose, HbA1c, and other covariates were measured by annual or biennial laboratory 
and physical examinations; thus, T2D diagnoses were made based on objective measures, unlike previous cohort 
studies. The mean age of the participants in the former study by Wennberg et al. and by Latham and Peek was 
48.8 years and 55.3 years, respectively19,20, while our study population was much younger, with a mean age of 38.3 
years. Furthermore, the study population consisted of asymptomatic examinees who participated in the health 
screening examination program; thus, the study findings from the low-risk population are less likely to be affected 
by survivor bias and biases related to comorbidities and use of multiple medications, compared to findings from 
previous cohorts. The present study, which used objective measures to diagnose T2D, demonstrated that poor 
SRH was significantly associated with an increased risk of T2D development, even in low-risk young Korean 
adults.
In the present study, we observed that a positive association between SRH and new-onset T2D was stronger 
in patients with an alcohol intake of <20 g/day compared to those with a higher alcohol intake of ≥2 g/day. The 
reasons for this are unclear, but people tend to reduce alcohol intake due to their comorbidities or health con-
cerns. Thus, these findings may be explained by the fact that the group who drank <20 g/day could have included 
former drinkers who might have reduced or stopped their alcohol intake because of other health issues41, indi-
cating that poor SRH in those who drank <20 g/day might imply a worse unmeasured condition. In addition, 
in most studies, moderate drinkers have been found to have good SRH compared with other types of drinkers42, 
and moderate drinkers have reported better health than nondrinkers43. Due to the use of multiple comparisons, 
chance may be another explanation for the observed difference across subgroups.
The exact mechanisms by which SRH predicts new-onset DM are not fully understood. T2D is closely related 
to unhealthy lifestyle habits that result in obesity, insulin resistance, and dyslipidemia. When people are faced 
with the question, “In general, how do you rate your health?” they may look back on their overall lifestyle and 
habits to evaluate and rate their health, beyond what is explained by objective measures that many studies usually 
assess. Studies have shown that SRH is associated with lifestyle factors such as exercise, overweight or obesity, 
and smoking, unhealthy meal planning choices, alcohol consumption, and genetic factors, all of which also have 
been associated with T2D11–13. In addition, because SRH involves a subjective health assessment that is influenced 
by different dimensions such as sociodemographic, physical, and psychological factors44,45, it may well reflect an 
individual’s specific situation. In addition, studies showed that poor self-rated health was associated with elevated 
inflammatory markers, a predictor for T2D, in adolescents and older adults14–16. Future studies are required to 
elucidate the mechanism underlying the predictive role of SRH on T2D development.
A few study limitations should be acknowledged. First, T2D was diagnosed based on single measurements 
of fasting glucose and HbA1c, whereas diagnostic criteria recommend confirmation by repeated testing; how-
ever, HbA1c has good pre-analytical stability and is less likely to be affected by acute perturbations (e.g., stress, 
exercise, or smoking)46. Second, waist circumference measurements, however, were available only in a fraction 
of study participants, limiting our ability to adjust central obesity as a confounder, which is a stronger indicator 
for insulin resistance and T2D incidence than BMI, especially in Asian populations44. Third, the SRH question 
used in this study was not directly validated in our study population, but previous studies have reported that 
SRH has high predictive and concurrent validity, as measured by its association with subsequent mortality and 
various measures of health outcomes8,9,47. Studies have also reported that the reliability of SRH is reliable in both 
adolescents and adult populations48–50. Fourth, a relatively short follow-up period with a median follow-up of 3.9 
years (interquartile 2.1–5.3 years, up to 6.9 years) is a limitation of this study. We performed sensitivity analysis 
by excluding subjects who developed T2D within the first 2 years of follow-up in order to consider whether the 
original results may have been influenced by reverse causality in which T2D was present, but undiagnosed. In 
this sensitivity analysis, the association between SRH and incident T2D was essentially unchanged (Appendix 
Table 2). Also, our study findings are in line with previous studies on the association between SRH and T2D that 
involved longer follow-up periods (9.1 years)19. Further studies with longer follow-up are required to determine 
the long-term predictive role of SRH on incident T2D. Fifth, information on SRH, medical history, lifestyle varia-
bles and depressive symptoms were collected using self-administered structured questionnaires. The possibility of 
measurement errors cannot be excluded for those variables, which might have resulted in some degree of residual 
confounding. Lastly, the study population consisted of young and middle-aged Koreans who regularly attended 
health-screening exams; thus, our findings might not be generalizable to other age groups, to populations with a 
higher prevalence of comorbidities, or to other racial/ethnic groups.
In conclusion, poor SRH was significantly associated with increased risk of developing T2D in young and 
middle-aged Korean men and women, after adjusting for confounding factors. Further mechanistic research is 
needed to elucidate the mechanism by which SRH predicts the incidence of T2D. Given the established value of 
SRH, one of the most widely used measures of general health in population health research, for predicting vari-
ous chronic diseases including T2D, clinicians involved in diabetes screening and management should routinely 
consider SRH when evaluating T2D risk as well as overall health.
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